Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

Cited by (505)

Items 301–400 of 505

1. Distinct soluble immune checkpoint profiles characterize COVID-19 severity, mortality and SARS-CoV-2 variant infections
   Tudorița Gabriela Părângă, Mariana Pavel Tanasa, Daniela Constantinescu, Elena Iftimi, Claudia Elena Plesca, Ionela-Larisa Miftode, Petru Cianga, Egidia Gabriela Miftode · 2024 · Frontiers in Immunology
2. Threading the Pieces Together: Integrative Perspective on SARS-CoV-2
   Akshay Kanakan, Neha Mishra, Janani Srinivasa Vasudevan, Shweta Sahni, Azka Khan, Sachin Sharma, Rajesh Pandey · 2020 · Pathogens
3. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities
   Modjtaba Emadi‐Baygi, Mahsa Ehsanifard, Najmeh Afrashtehpour, Mahnaz Norouzi, Zahra Joz-Abbasalian · 2021 · Frontiers in Immunology
4. Role of the cellular immunity in the formation of the immune response in coronavirus infections
   Ivanova Ia, N. D. Omelchenko, Anna V. Filippenko, Anastasia A. Trufanova, А. К. Носков · 2021 · Medical Immunology (Russia)
5. Connecting the dots between inflammatory cascades of obesity and COVID-19 in light of mortal consequences—a review
   Payel Mal, Tuhin Mukherjee, Abhay Kumar Upadhyay, Satyajit Mohanty, Ashok Kumar Pattnaik · 2022 · Environmental Science and Pollution Research
6. The function of myeloid-derived suppressor cells in COVID-19 lymphopenia
   Taosan Li, Fang Zheng, Fanjun Cheng · 2022 · International Immunopharmacology
7. Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study
   Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, Jose Garay Umanzor, Fernando Baires, Luis G. Benitez, Cesar Burgos, Anupamjeet Kaur Sekhon, Nicole Crisp, Anita S. Lewis et al. · 2022 · Frontiers in Pharmacology
8. Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity
   Thai Hien Tu, Ami Grunbaum, François Santinon, Alexandra Kazanova, Nicholas Rozza, Richard B. Kremer, Catalin Liviu Dragos Mihalcioiu, Christopher E. Rudd · 2024 · Communications Biology
9. Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis
   Manuel Ruiz-Pablos, Bruno Paiva, Aintzane Zabaleta · 2024 · Frontiers in Immunology
10. From pandemic onset to present: five years of insights into ARDS caused by COVID-19
    Esteban Ortiz‐Prado, Juan S. Izquierdo‐Condoy, Jorge Vásconez-González, Andrés López‐Cortés, Camila Salazar-Santoliva, Alfonso Roberto Vargas Michay, Jorge Luís Vélez-Páez, Luis Unigarro · 2025 · Expert Review of Respiratory Medicine
11. Evaluation of hematological indices in terms of COVID-19 related mortality and ICU admission
    Özgür Yıldırım, Mehmet Bayram, Raye Sevra ÖZMEN, Beyza Soylu, Ahmet Dündar, Ali Rıza Köksal, İskender Ekinci, Murat Akarsu, Ömür Tabak · 2021 · Journal of Health Sciences and Medicine
12. High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019
    Money Gupta, Harikrishnan Balachandran, Raymond H. Y. Louie, Hui Li, David Agapiou, Elizabeth Keoshkerian, Daniel Christ, William D. Rawlinson, Michael Mina, Jeffrey John Post et al. · 2022 · Immunology and Cell Biology
13. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls
    Ali Mert, Haluk Vahaboğlu, Ferhat Arslan, Ayşe Alga Batırel, Kemal Tolga Saraçoğlu, Aliye Baştuğ, Atahan Çağatay, İlim Irmak, Gülçin Telli Dizman, İhsan Ertenli et al. · 2021 · Rheumatology International
14. Evaluation of the Predictive Value of C-reactive Protein, Interleukin-6 and Their Derived Immune-Inflammatory Indices in COVID-19 Egyptian Patients
    Sara Taha, Aalaa K. Shata, Eman Mousa El-Sehsah, Shaimaa Hani Fouad, Aya Hisham Moussa Ahmad, Shaimaa Abdalaleem Abdalgeleel, Nouran Magdy Moustafa, Mariam Karam Youssef · 2021 · Microbes and Infectious Diseases /Microbes and Infectious Diseases
15. Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
    Agustín Valenzuela-Fernández, Romina Cabrera-Rodríguez, Laura Ciuffreda, Silvia Pérez-Yanes, Judith Estévez‐Herrera, Rafaela González‐Montelongo, Julia Alcoba-Flórez, Rodrigo Trujillo‐González, Diego García-Martínez de Artola, Helena Gil-Campesino et al. · 2022 · Frontiers in Bioengineering and Biotechnology
16. Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics
    Maryam Sayahinouri, Sahar Mashayekhi Firouz, Amin Ebrahimi Sadrabadi, Mina Masoudnia, Mahnaz Abdolahi, Fatemeh Jafarzadeh, Meshkat Nouripour, Sana Mirzazadeh, Nazanin Zangeneh, Arsalan Jalili et al. · 2023 · Bioimpacts
17. Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2
    Xiangning Zhang, Longji Wu, Xia Kong, Biying Zheng, Zhe Zhang, Zhiwei He · 2021 · World Journal of Clinical Cases
18. Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients
    Andrea Sacconi, Claudia De Vitis, Luisa de Latouliere, Simona Di Martino, Francesca De Nicola, Frauke Goeman, Carla Mottini, Francesca Paolini, Michela D’Ascanio, Alberto Rícci et al. · 2021 · Cell Death and Disease
19. Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution
    Sara Garcinuño, Francisco Javier Gil‐Etayo, Esther Mancebo, Marta López-Nevado, Antonio Lalueza, Raquel Díaz‐Simón, Daniel Enrique Pleguezuelo, Manuel Serrano, Óscar Cabrera-Marante, Luis Miguel Allende et al. · 2022 · International Journal of Molecular Sciences
20. Peripheral Blood Mononuclear Cells and Serum Cytokines in Patients with Lupus Nephritis after COVID-19
    Katarzyna Aleksandra Lisowska, Klaudia Ciesielska-Figlon, Michał Komorniczak, Barbara Bułło‐Piontecka, Alicja Maria Dębska-Ślizień, Anna Wardowska · 2024 · International Journal of Molecular Sciences
21. Can alpha‐linolenic acid be a modulator of “cytokine storm,” oxidative stress and immune response in SARS‐CoV‐2 infection?
    Danila Cianciosi, Yasmany Armas Díaz, Antonio Vittorino Gaddi, Fabio Capello, Maria Teresa Savo, Ramón del Jesús Palí Casanova, Julio César Martínez Espinosa, Alina Eugenia Pascual Barrera, María D. Navarro‐Hortal, Lingmin Tian et al. · 2023 · Food Frontiers
22. Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury
    Zhaoqing Li, Luning Qin, Xiaojian Xu, Ruolan Chen, Guoliang Zhang, Banghui Wang, Bing Li, Xian‐Ming Chu · 2025 · Frontiers in Immunology
23. COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study
    Olga L. Kochneva, Maria I. Kislova, Evgenia I. Zhelnova, Andrei A. Petrenko, Elena Alexandrovna Baryakh, K. V. Yatskov, Elena A. Dmitrieva, Elena N Misyurina, Konstantin E. Nikitin, Elena Vasilieva et al. · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
24. Characteristics of Natural Killer (NK) Cell and T Lymphocyte in COVID-19 patients in Surabaya, Indonesia
    Munawaroh Fitriah, Betty Agustina Tambunan, Hartono Kahar, Jusak Nugraha, Fauqa Arinil Aulia, Aryati Aryati, Resti Yudhawati, Sudarsono Sudarsono, Damayanti Tinduh, Cita Rosita Sigit Prakoeswa et al. · 2022 · Research Journal of Pharmacy and Technology
25. Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19
    Heejin Nam, June‐Young Koh, Jae Hyung Jung, Hyeongseok Jeong, Hye Won Jeong, Shinhye Cheon, Su‐Hyung Park, Kim Ys, Eui‐Cheol Shin · 2023 · The Journal of Immunology
26. Identification of natural killer markers associated with fatal outcome in COVID-19 patients
    Nadine Tarantino, Elena Litvinova, Assia Samri, Cathia Soulié, Véronique Morin, Alice Rousseau, Karim Dorgham, Christophe Parizot, Olivia Bonduelle, Alexandra Beurton et al. · 2023 · Frontiers in Cellular and Infection Microbiology
27. COVID‐19 associated mucormycosis surge: A review on multi‐pathway mechanisms
    Mohsen Pourazizi, Atousa Hakamifard, Alireza Peyman‎, Rasoul Mohammadi, Shakiba Dehghani, Najmeh Tavousi, Nastaran Hosseini, Hamed Azhdari Tehrani, Bahareh Abtahi‐Naeini · 2023 · Parasite Immunology
28. Excess of body weight is associated with accelerated T-cell senescence in hospitalized COVID-19 patients
    Mailton Prestes Madruga, Lucas Kich Grün, Letícya Simone Melo Dos Santos, Frederico Friedrich, Douglas Bitencourt Antunes, Marcella Elesbão Fogaça Rocha, Pedro Luís Silva, Gilson Pires Dorneles, Paula Coelho Teixeira, Tiago Franco de Oliveira et al. · 2024 · Immunity & Ageing
29. Immune Response Failure in Paucisymptomatic Long-Standing SARS-CoV-2 Spreaders
    Salvatore Corrao, Francesco Gervasi, Francesca Di Bernardo, Christiano Argano · 2021 · Clinics and Practice
30. A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19
    Joo Guan Yeo, Jing Yao Leong, Shi Huan Tay, Karen Donceras Nadua, Danielle E. Anderson, Amanda Jin Mei Lim, Xiang Wen Ng, Su Li Poh, Dianyan Guo, Katherine Nay Yaung et al. · 2021 · Frontiers in Immunology
31. Advances in clinical outcomes: What we have learned during the COVID-19 pandemic
    Amer Al-Musa, Brenna LaBere, Saddiq B. Habiballah, Alan A. Nguyen, Janet S. Chou · 2021 · Journal of Allergy and Clinical Immunology
32. Underlying Co-Morbidity Reveals Unique Immune Signatures in Type II Diabetes Patients Infected With SARS-CoV2
    Soumya Sengupta, Gargee Bhattacharya, Sanchari Chatterjee, Ankita Datey, Shubham K. Shaw, Sandhya Suranjika, Paritosh Nath, Prakash K. Barik, Punit Prasad, Soma Chattopadhyay et al. · 2022 · Frontiers in Immunology
33. Clinical Relevance of Elevated Soluble ST2, HSP27 and 20S Proteasome in Patients with COVID-19
    Ralph T. Wendt, Marie‐Therese Lingitz, Maria Laggner, Michael Mildner, Denise Traxler, Alexandra Christine Graf, Pavla Krotka, Bernhard Moser, Konrad Höetzenecker, Sven Kalbitz et al. · 2021 · Preprints.org
34. The Journal of Clinical Investigation in the time of COVID-19
    Arturo Casadevall, Sarah Jackson, Gregg L. Semenza, Gordon F. Tomaselli, Rexford S. Ahima · 2021 · Journal of Clinical Investigation
35. High Frequencies of Phenotypically and Functionally Senescent and Exhausted CD56 + CD57 + PD-1 + Natural Killer Cells, SARS-CoV-2-Specific Memory CD4 + and CD8 + T cells Associated with Severe Disease in Unvaccinated COVID-19 Patients
    Ruchi Srivastava, Nisha Rajeswari Dhanushkodi, Swayam Prakash, Pierre-Gregoire A. Coulon, Hawa Vahed, Latifa Zayou, Afshana Quadiri, Lbachir BenMohamed · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
36. Combination of cycle threshold time, absolute lymphocyte count and neutrophil:lymphocyte ratio is predictive of hypoxia in patients with SARS-CoV-2 infection
    Visula Abeysuriya, Suranjith Luke Seneviratne, Arjuna Priyadarsin De Silva, Riaz Mowjood, Shazli Mowjood, Thushara de Silva, Primesh de Mel, Chandima de Mel, Lal Gotabhaya Chandrasena, R S Wijesinha et al. · 2021 · Transactions of the Royal Society of Tropical Medicine and Hygiene
37. NK Cell and Monocyte Dysfunction in Multisystem Inflammatory Syndrome in Children
    Jenna K. Dick, Jules A. Sangala, Venkatramana Divana Krishna, Aaron Khaimraj, Lydia Hamel, Spencer M Erickson, Dustin M. Hicks, Yvette Soigner, Laura Covill, Alexander K. Johnson et al. · 2024 · The Journal of Immunology
38. Effector memory T cell subset CD45RA−CCR7−CD27−CD28 − EM3 increases in direct proportion to the disease severity of COVID ‐19
    Muhammed Ali Kızmaz, Abdurrahman Şimşek, Tuğçe Bozkurt, Eren Çağan, Fatma Dombaz, Gülçin Tezcan, Ali Aşan, Halil Ibrahim Demir, Salih Haldun Bal, Diğdem Yöyen-Ermiş et al. · 2022 · Scandinavian Journal of Immunology
39. Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination
    Ece Tavukçuoğlu, Hamdullah Yanık, Mubaida Parveen, Sıla Ulutürk, Mine Durusu Tanrıöver, Ahmet Çağkan İnkaya, Murat Akova, Serhat Ünal, Güneş Esendağlı · 2023 · Scientific Reports
40. Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV
    Márton Kolossváry, Christopher R. deFilippi, Sara McCallum, Kathleen V. Fitch, Marissa R Diggs, Evelynne S. Fulda, Heather Jane Ribaudo, Carl J. Fichtenbaum, Judith A. Aberg, Carlos Malvestutto et al. · 2023 · EBioMedicine
41. Alterations in the CD56− and CD56+ T Cell Subsets during COVID-19
    Julia D. Vavilova, Maria O. Ustiuzhanina, Anna A. Boyko, Maria A. Streltsova, Sofya A. Kust, Leonid M. Kanevskiy, Rustam N. Iskhakov, Alexander M. Sapozhnikov, Ekaterina O. Gubernatorova, Marina S. Drutskaya et al. · 2023 · International Journal of Molecular Sciences
42. Immunomodulatory effect of IFN-γ licensed adipose-mesenchymal stromal cells in an in vitro model of inflammation generated by SARS-CoV-2 antigens
    Elizabete Cristina Iseke Bispo, Enrique Roberto Argañaraz, Francisco de Assis Rocha Neves, Juliana Lott Carvalho, Felipe Saldanha‐Araújo · 2024 · Scientific Reports
43. The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study
    Sergey V Efimov, N. V. Matsiyeuskaya, Olga V Boytsova, Lyudmila Yu Akhieva, Elena I Kvasova, Francisco Harrison, Yulia S Karpova, Anton A. Tikhonov, Nadezhda F Khomyakova, Timothy Colin Hardman et al. · 2021 · Drugs in Context
44. SARS-CoV-2 Associated Immune Dysregulation and COVID-Associated Pulmonary Aspergilliosis (CAPA): A Cautionary Tale
    Dominic Adam Worku · 2022 · International Journal of Molecular Sciences
45. Tocilizumab Accelerates Recovery in Patients With Severe COVID-19 Pneumonia on Venovenous Extracorporeal Membrane Oxygenation
    Tyler C. Lewis, Serena Arnouk, Bridget Toy, Travis C. Geraci, Julius A. Carillo, Stephanie H. Chang, Nader Moazami, Zachary N. Kon, Deane E. Smith · 2022 · ASAIO Journal
46. Apparent Association of Insulin With Interleukin-6 (IL-6) in Severe COVID-19 Patients Having Chronic Disease Comorbidities
    Fatimah A Nouh, Hajir Othman, Enass K Gwarsha, Agila A Elbadry, Akram Alabdali, I. F. Barassi, Salem Elamary, Abdelsalam A Elbadry, Farag A Elshaari · 2022 · Cureus
47. Characteristics and Potential Roles of Natural Killer Cells During SARS-CoV-2 Infection
    Wenjing Cao, Fu‐Sheng Wang, Jin‐Wen Song · 2022 · Infectious Diseases & Immunity
48. SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model
    Rúbens Prince dos Santos Alves, Ying-Ting Wang, Zbigniew Mikulski, Sara McArdle, Norazizah Shafee, Kristen M. Valentine, Robyn Miller, Shailendra Kumar Verma, Fernanda Ana‐Sosa‐Batiz, Erin Maule et al. · 2023 · Antiviral Research
49. INSIGHT OF PANDEMIC COVID-19: DEVELOPMENTS AND CHALLENGES
    Muhammad Akram Muneer, M. Arshad, Ghulam Abbas, Maria Arshad, K. Munir, A. Iqbal, A. Mustafa, Q. Amin, Mumtaz Ahmad Khan, Razia AbdulMajid Qureshi et al. · 2023 · Pakistan Journal of Science
50. Epigenetic regulation of Epstein–Barr virus: From bench to bedside
    Xiao Yan Gao, Hao-Xu Yang, Shu Cheng, Huaman Cai, Jie Xiong, Weili Zhao · 2024 · Clinical and Translational Discovery
51. Clinical effect of early administration of tocilizumab following the initiation of corticosteroid therapy for patients with COVID-19
    Takaya Kawamata, Yoshinori Tanino, Takefumi Nikaido, Hiroyuki Minemura, Yuki Sato, Ryuichi Togawa, Natsumi Watanabe, Ryuki Yamada, Riko Sato, Takumi Onuma et al. · 2022 · Journal of Infection and Chemotherapy
52. SARS-CoV-2 Immunity in Hematopoietic Stem Cell Transplant and Cell Therapy Recipients: What Do We Know, and What Remains to Be Determined?
    José Luís Piñana, Manuel Guerreiro, Carlos Solano · 2023 · Hemato
53. Potential network markers and signaling pathways for B cells of COVID-19 based on single-cell condition-specific networks
    Ying Li, Liqin Han, Peiluan Li, Jing Ge, Yun Xue, Luonan Chen · 2023 · BMC Genomics
54. CD151 identifies an NK cell subset that is enriched in COVID-19 patients and correlates with disease severity
    Ainhoa Amarilla-Irusta, Olatz Zenarruzabeitia, Arrate Sevilla, Víctor Sandá, Ainara Lopez-Pardo, Gabirel Astarloa-Pando, Raquel Pérez-Garay, Sílvia Pérez-Fernández, Susana Meijide, Natale Imaz-Ayo et al. · 2024 · Journal of Infection
55. Immune profile of children diagnosed with multisystem inflammatory syndrome associated with SARS-CoV-2 infection (MIS-C)
    Ewelina Gowin, Grzegorz Dworacki, Bartosz Siewert, Jacek Wysocki, Danuta Januszkiewicz‐Lewandowska · 2022 · Central European Journal of Immunology
56. Intervention Effects of Physical Activity on Type 2 Diabetic Patients Potentially Infected with COVID-19
    Lihua Yu, Sainyu Guo, Wen Ji, Hailian Sun, Seong-no Lee, Deju Zhang · 2023 · Medicina
57. Adjunctive treatment in COVID-19 and sepsis—What did we learn?
    Evangelos J. Giamarellos‐Bourboulis · 2023 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
58. Herpes Zoster Duplex Unilateralis as a manifestation of severe lymphopenia in COVID19
    Puneet Bhargava, Heena Singdia, Rachita Mathur, Rohit Garg, Neha Rani, Shivi Nijhawan, Deepika Kothari · 2020 · European Journal of Pain
59. Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2
    Katarzyna Piadel, Amin Haybatollahi, Angus George Dalgleish, Peter Lawrence Smith · 2022 · Journal of General Virology
60. Identification and characterization of an immunodominant SARS-CoV-2-specific CD8 T cell response
    Anastasia Gangaev, Steven L. C. Ketelaars, Olga I. Isaeva, Sanne Patiwael, Anna Dopler, Kelly Hoefakker, Sara De Biasi, Lara Gibellini, Cristina Mussini, Giovanni Guaraldi et al. · 2020
61. SARS-COV-2 NSP5 Antagonizes MHC II Expresion by Subverting Histone Deacetylase 2
    Nima Taefehshokr, Alex Lac, Angela M. Vrieze, Brandon H. Dickson, Peter N. Guo, Catherine Jung, Eoin N. Blythe, Corby Fink, Amena Aktar, Jimmy Dimitrios Dikeakos et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
62. Pathological Effects of SARS-CoV-19 Associated With Hematological Abnormalities
    Mrs Shama, Asif Mahmood, Shahid Mehmood, Wen Zhang · 2023 · Preprints.org
63. SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters
    Ming-Shu Hsieh, Chia-Wei Hsu, Hung‐Chun Liao, Chang-Ling Lin, Chen-Yi Chiang, Mei‐Yu Chen, Shih‐Jen Liu, Ching‐Len Liao, Hsin–Wei Chen · 2024 · Journal of Virology
64. Effector CD8 T cell differentiation in primary and breakthrough SARS-CoV-2 infection in mice
    Brock A. Kingstad-Bakke, Woojong Lee, Boyd L. Yount, Thomas Cleven, Hong-Tae Park, Jeremy A. Sullivan, Ralph Steven Baric, M. Suresh · 2025 · Communications Biology
65. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
    Tarek Seifaw Kashour, Imad M. Tleyjeh · 2021 · Clinical Microbiology and Infection
66. Comparison of T Lymphocyte Subsets and Natural Killer Lymphocytes in Moderate Versus Severe COVID-19 Patients
    Hala Metwally Gabr, Asmaa A. Abdel_Aal, Samah Bastawy, Mohamed Fateen, Omnia Abd El Dayem, Eman A. Youssef, Rania Mohamed Afifi, Mostafa Kamal · 2023 · Viral Immunology
67. Incompetent memory immune response in severe COVID-19 patients under treatment
    Shukla Das, Gargi Rai, Vikas Sood, Praveen Kumar Singh, Asha Tyagi, Rashmi Salhotra, Chhavi Gupta, Vinita Kumar Jaggi, Sajad Ahmad Dar, M A Ansari · 2023 · Heliyon
68. Evaluating the levels of Tumor Necrosis Factorα-, Interleukin-6 and Vascular endothelial growth factor in patients with Colorectal Cancer
    Fenik Ahmed Nadir, Zeyan Abdullah Ali · 2023 · Iraqi Journal of Science
69. Differences in Characteristics of T-Cell Immunity to SARS-CoV-2 in Clinically Healthy Subjects
    Сушенцева Наталья Николаевна, Олег Сергеевич Попов, Ирина Андреевна Полковникова, S. V. Al’pako, Sergey G. Shcherbak · 2022 · Bulletin of Experimental Biology and Medicine
70. CHARM: COVID-19 Health Action Response for Marines–Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test
    Martha Sedegah, Chad K. Porter, Michael R. Hollingdale, Harini D. Ganeshan, Jun Huang, Carl W. Goforth, María Belmonte, Arnel D. Belmonte, Dawn L. Weir, Rhonda A. Lizewski et al. · 2022 · PLoS ONE
71. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
    Wbeimar Aguilar-Jiménez, Lizdany Flórez‐Álvarez, Daniel S. Rincón, Damariz Marín-Palma, Alexandra Sánchez-Martínez, Jahnnyer Martínez-Moreno, Maria Isabel Zapata-Cardona, John D. Loaiza, Constanza Cárdenas, Fanny Guzmán et al. · 2021 · Biomédica
72. Systematic Investigation of a Potential Epidemiological and Genetic Association Between Male Androgenetic Alopecia and COVID-19
    Sabrina K. Henne, Lara M. Hochfeld, Carlo Maj, Markus Maria Nöthen, Stefanie Heilmann‐Heimbach · 2021 · Skin Health and Disease
73. Longitudinal analyses reveal age-specific immune correlates of COVID-19 severity
    Sloan A. Lewis, Suhas Sureshchandra, Michael Z. Zulu, Brianna M. Doratt, Amanda N. Pinski, Micaila Curtis, Allen Jankeel, Izabela Coimbra Ibraim, Nicholas S. Rhoades, Xiwen Jiang et al. · 2021 · medRxiv
74. Untangling the cell immune response dynamic for severe and critical cases of SARS-CoV-2 infection
    Rodolfo Blanco‐Rodríguez, Xin Du, Esteban Abelardo Hernandez-Vargas · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
75. Risk factors for critical-ill events of patients with COVID-19 in Wuhan, China: a retrospective cohort study
    Sen Yang, Le Ma, Yulan Wang, Qian Wang, Qiang Tong, Miao Chen, Hua Zhang, Dehua Yu, Sheng‐Ming Dai, Ran Cui · 2020 · medRxiv
76. High Frequencies of PD-1 + TIM3 + TIGIT + CTLA4 + Functionally Exhausted SARS-CoV-2-Specific CD4 + and CD8 + T Cells Associated with Severe Disease in Critically ill COVID-19 Patients
    Pierre-Gregoire A. Coulon, Swayam Prakash, Nisha Rajeswari Dhanushkodi, Ruchi Srivastava, Latifa Zayou, Delia F. Tifrea, Robert A. Edwards, J. Figueroa Cesar, Sebastian Dominik Schubl, Lanny L. Hsieh et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
77. Pathogenicity, immunogenicity, and protective ability of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein
    Pui Wang, Siu-Ying Lau, Shaofeng Deng, Pin Chen, Bobo Wing-Yee Mok, Jinxia Zhang, Andrew Chak-Yiu Lee, Kwok‐Hung Chan, Wenjun Song, Kelvin Kai‐Wang To et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
78. Can there be calm during a cytokine storm? Immune checkpoint pathways affecting the severity of COVID-19 disease
    Mátyás Meggyes, Dávid U. Nagy, Ildiko Toth, Timoteus Feik, Ágnes Péterfalvi, Beáta Polgár, Dávid Sipos, Ágnes Kemény, László Szereday · 2024 · Frontiers in Microbiology
79. Insights into dysregulated innate immunity in the pathogenesis of COVID-19-associated pulmonary aspergillosis
    Hanxue Xiang, Ling Zhang, Miaotian Cai, Yulin Zhang · 2025 · Infection
80. The innate immune response in SARS-CoV2 infection: focus on toll-like receptor 4 in severe disease outcomes
    Enrico Maggi, Nadine Landolina, F. Mariotti, E. Munari, Nicola Tumino, P. Vacca, B. Azzarone, Lorenzo Moretta · 2025 · Frontiers in Immunology
81. COVID-19 Disease in Pediatric Solid Organ Transplantation from Alpha to Omicron: A High Monocyte Count in the Preceding Three Months Portends a Risk for Severe Disease
    Yasmina Sirgi, Maja Stanojevic, Jaeil Ahn, Nada A. Yazigi, Stuart S. Kaufman, Khalid Khan, Bernadette E. Vitola, Cal Matsumoto, Alexander Kroemer, Thomas Fishbein et al. · 2023 · Viruses
82. Obesity in Severe COVID-19 Patients Has a Distinct Innate Immune Phenotype
    Ayane de Sá Resende, Y. L. M. de Oliveira, M. F. D. de Franca, L. Magalhães, Cristiane Bani Corrêa, K. Fukutani, Michael W. Lipscomb, T. D. de Moura · 2023 · Biomedicines
83. Evaluation of the lymphocyte population and placental inflammation in pregnant patients with moderate or severe COVID-19 forms – a secondary analysis
    Adina Elena Tănase, Raluca Anamaria Mogoş, Simona Juliette Mogoş, Ştefana Raluca Bran, Tudor Gîscă, Iustina Petra Solomon-Condriuc, Claudia Florida Costea, Gabriel Valentin Tănase, Andrei Ionuț Cucu · 2024 · Romanian Journal of Morphology and Embryology
84. Clinical Features of COVID‐19 Associated Pulmonary Aspergillosis: A Multicenter, Retrospective Study
    Yasheng Zhan, Guojun He, Cheng Zhong, Yake Yao, Jiangying Zhou, Tong Li, Hua Zhou · 2025 · The Clinical Respiratory Journal
85. ScRNA-Seq reveals T cell immunity in COVID-19 patients and implications for immunotherapy
    Zhihong Yao, Zhao Feng, Hui Zhang, Baojun Zhang · 2025 · International Immunopharmacology
86. NK cells at the crossroads in COVID-19: a question of timing
    Susana del Toro‐Arreola, Fabiola Solorzano Ibarra, Martha Cecilia Téllez‐Bañuelos, Jesse Haramati · 2020 · Ciencia Tecnologí­a y Salud
87. Rationale for Randomized Clinical Trials Investigating the Potential of BCG Vaccination in Preventing COVID-19 Infection
    Magali Noval Rivas, Charles Joel Rosser, Moshe Arditi · 2021 · Bladder Cancer
88. Immunoediting in SARS-CoV-2: Mutual relationship between the virus and the host
    Nasim Kheshtchin, Parisa Bakhshi, Samaneh Arab, Maryam Nourizadeh · 2022 · International Immunopharmacology
89. Dynamic response landscape of immune cells identified immune dysfunction which predicts disease progression in COVID-19 infected patients
    Xiangyu Deng, Yao Zhang, Meiqi Li, Xiaolong Tang, Yu Chen, Yu Chen, Yueshui Zhao, Qinglian Wen, Xu Wu, Jing Li et al. · 2022 · International Journal of Biological Sciences
90. COVID-19
    Lisa A. Beltz · 2022 · Elsevier eBooks
91. The liver-to-spleen ratio is a risk factor predicting oxygen demand in COVID-19 patients
    Hiromasa Nakayasu, Shogo Sakurai, Shuichi Sugiyama, Kotaro Shiratori, Kohei Okawa, Yoshihiro Kitahara, Shingo Takahashi, Toshihiro Masuda, Yutaro Kishimoto, Mika Saigusa et al. · 2023 · Infectious Medicine
92. Quizartinib inhibits necroptosis by targeting receptor‐interacting serine/threonine protein kinase 1
    Min Li, Jun Wei, Guofeng Zhu, Shufang Fu, Xiaoyan He, Xinqian Hu, Yajie Yu, Yan Mou, Jia Wang, Xiaoling You et al. · 2023 · The FASEB Journal
93. A Review on Role of Inflammation in Coronavirus Disease
    Arezoo Lotfi, Pouran Hajian, Laleh Abbasi, Morad Kohandel Gargari, Najmeh Nameh Goshay Fard, Delaram Naderi · 2024 · Endocrine Metabolic & Immune Disorders - Drug Targets
94. Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency
    Lucy Kundura, Renaud Cezar, Emma Ballongue, Sónia André, Moïse Michel, Clément Mettling, Claire Lozano, Thierry Vincent, Laurent Müller, Jean‐Yves Lefrant et al. · 2024 · The Journal of Immunology
95. Coronavirus disease 2019 in critically ill patients: can we re-program the immune system? A primer for Intensivists
    Fiorenza Ferrari, Federico Visconti, Mara DE AMICI, Angelo Guglielmi, Costanza Natalia Julia Colombo, Mirko Belliato, Claudio Ronco · 2020 · Minerva Anestesiologica
96. Severe Acute Respiratory Syndrome Coronavirus 2: Manifestations of Disease and Approaches to Treatment and Prevention in Humans
    Michael E. Watson, Kengo Inagaki, Jason B. Weinberg · 2021 · Comparative Medicine
97. Risk Factors for Critical-Ill Events of Patients With COVID-19 in Wuhan, China: A Retrospective Cohort Study
    Sen Yang, Le Ma, Yulan Wang, Qian Wang, Qiang Tong, Miao Chen, Hua Zhang, Dehua Yu, Sheng‐Ming Dai, Ran Cui · 2020
98. Enhanced eosinophilic inflammation associated with antibody and complement-mediated pneumonic insults in severe COVID-19
    Dong‐Min Kim, Jun-Won Seo, Yuri Kim, Joo-Yeon Lee, Uni Park, Na‐Young Ha, Jaemoon Koh, Hyoree Park, Jaewon Lee, Hyo‐Jin Ro et al. · 2020
99. Diet induced obesity and type 2 diabetes drives exacerbated sex-associated disease profiles in K18-hACE2-mice challenged with SARS-CoV-2
    Katherine S. Lee, Brynnan P. Russ, Ting Y. Wong, Alexander M. Horspool, Michael T. Winters, Mariette Barbier, Justin R. Bevere, Iván Martínez, Fredrick Heath Damron, Holly A. Cyphert · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
100. The role of T cell immunity in COVID-19
     Ulrik Stervbo, Nina Babel · 2023 · Elsevier eBooks